Solventum price target raised to $82 from $79 at Wells Fargo

Wells Fargo raised the firm’s price target on Solventum (SOLV) to $82 from $79 and keeps an Equal Weight rating on the shares. The firm is updating its price target on the stock to reflect the sale of the company’s P&F business, the analyst tells investors.